GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Patterson Companies Inc (NAS:PDCO) » Definitions » ROE %

Patterson (Patterson) ROE %

: 18.84% (As of Jan. 2024)
View and export this data going back to 1992. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Patterson's annualized net income for the quarter that ended in Jan. 2024 was $191 Mil. Patterson's average Total Stockholders Equity over the quarter that ended in Jan. 2024 was $1,013 Mil. Therefore, Patterson's annualized ROE % for the quarter that ended in Jan. 2024 was 18.84%.

The historical rank and industry rank for Patterson's ROE % or its related term are showing as below:

PDCO' s ROE % Range Over the Past 10 Years
Min: -50.92   Med: 14.04   Max: 20.27
Current: 18.1

During the past 13 years, Patterson's highest ROE % was 20.27%. The lowest was -50.92%. And the median was 14.04%.

PDCO's ROE % is ranked better than
89.47% of 95 companies
in the Medical Distribution industry
Industry Median: 7.24 vs PDCO: 18.10

Patterson ROE % Historical Data

The historical data trend for Patterson's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Patterson Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.69 -50.92 17.36 20.27 19.23

Patterson Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.14 27.03 11.22 14.77 18.84

Competitive Comparison

For the Medical Distribution subindustry, Patterson's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Patterson ROE % Distribution

For the Medical Distribution industry and Healthcare sector, Patterson's ROE % distribution charts can be found below:

* The bar in red indicates where Patterson's ROE % falls into.



Patterson ROE % Calculation

Patterson's annualized ROE % for the fiscal year that ended in Apr. 2023 is calculated as

ROE %=Net Income (A: Apr. 2023 )/( (Total Stockholders Equity (A: Apr. 2022 )+Total Stockholders Equity (A: Apr. 2023 ))/ count )
=207.557/( (1041.676+1117.535)/ 2 )
=207.557/1079.6055
=19.23 %

Patterson's annualized ROE % for the quarter that ended in Jan. 2024 is calculated as

ROE %=Net Income (Q: Jan. 2024 )/( (Total Stockholders Equity (Q: Oct. 2023 )+Total Stockholders Equity (Q: Jan. 2024 ))/ count )
=190.812/( (1054.296+971.482)/ 2 )
=190.812/1012.889
=18.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jan. 2024) net income data. ROE % is displayed in the 30-year financial page.


Patterson  (NAS:PDCO) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jan. 2024 )
=Net Income/Total Stockholders Equity
=190.812/1012.889
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(190.812 / 6464.38)*(6464.38 / 2914.8195)*(2914.8195 / 1012.889)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.95 %*2.2178*2.8777
=ROA %*Equity Multiplier
=6.54 %*2.8777
=18.84 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jan. 2024 )
=Net Income/Total Stockholders Equity
=190.812/1012.889
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (190.812 / 247.76) * (247.76 / 280.048) * (280.048 / 6464.38) * (6464.38 / 2914.8195) * (2914.8195 / 1012.889)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7701 * 0.8847 * 4.33 % * 2.2178 * 2.8777
=18.84 %

Note: The net income data used here is four times the quarterly (Jan. 2024) net income data. The Revenue data used here is four times the quarterly (Jan. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Patterson ROE % Related Terms

Thank you for viewing the detailed overview of Patterson's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Patterson (Patterson) Business Description

Traded in Other Exchanges
Address
1031 Mendota Heights Road, Saint Paul, MN, USA, 55120
Patterson Companies Inc is a leading dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives a majority of its revenue from the United States.
Executives
Kevin Michael Barry officer: Chief Financial Officer 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Donald Zurbay officer: Chief Financial Officer C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Timothy E Rogan officer: President - Dental 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Les B Korsh officer: VP, General Counsel 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55110
Meenu Agarwal director 7246 E MERCER WAY, MERCER ISLAND WA 98040
Samantha L Bergeson officer: CHRO 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Andrea L. Frohning officer: Chief Human Resources Officer C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Philip Mckoy director 120 BROADWAY, SUITE 200, SANTA MONICA CA 90401
Jody H Feragen director 1 HORMEL PLACE, AUSTIN TX 55912
Eric R Shirley officer: President-Patterson Dental 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Francis Joseph Malecha director 9900 WEST 109TH STREET, SUITE 100, OVERLAND PARK KS 66210
Robert Frenzel director 414 NICOLLET MALL, MINNEAPOLIS MN 55401
Dennis W Goedken officer: Interim CFO 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Ann B Gugino officer: Vice President 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
John D Buck director 4201 GULF SHORE BLVD NORTH, APT 1703N, NAPLES FL 34103